Paper35995341
STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges.
Wong GL and 3 others. Semin Cancer Biol, 2022. Cited by 96 papers, by iCite.
Cite this record
ConductScience Library. STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges. Papers, record 35995341. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35995341
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Neoplasms, Second Primary | Major topic |
| Female | |
| Humans | |
| Neoplasm Recurrence, Local | |
| Neoplastic Stem Cells | |
| Carcinogenesis |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| F31 CA261027 | NCI NIH HHS | United States | F31CA261027 | PubMed and NIH | NIH RePORTER |
| P30 CA012197 | NCI NIH HHS | United States | P30CA012197 | PubMed and NIH | NIH RePORTER |
| R01 CA228137 | NCI NIH HHS | United States | R01CA228137 | PubMed and NIH | NIH RePORTER |
References419
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34066153 | TrkA Interacts with and Phosphorylates STAT3 to Enhance Gene Transcription and Promote Breast Cancer Stem Cells in Triple-Negative and HER2-Enriched Breast Cancers. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34066153 | PubMed |
| 2 | 8085155 | An interleukin-4-induced transcription factor: IL-4 Stat. | Science | 1994 | https://conductscience.org/library/papers/8085155 | PubMed |
| 3 | 31081058 | Phospho‑STAT1 expression as a potential biomarker for anti‑PD‑1/anti‑PD‑L1 immunotherapy for breast cancer. | Int J Oncol | 2019 | https://conductscience.org/library/papers/31081058 | PubMed |
| 4 | 17216035 | Structure, function, and regulation of STAT proteins. | Mol Biosyst | 2006 | https://conductscience.org/library/papers/17216035 | PubMed |
| 5 | 32738343 | MiR-375 inhibits the stemness of breast cancer cells by blocking the JAK2/STAT3 signaling. | Eur J Pharmacol | 2020 | https://conductscience.org/library/papers/32738343 | PubMed |
| 6 | 10202937 | Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling. | Nat Med | 1999 | https://conductscience.org/library/papers/10202937 | PubMed |
| 7 | 16293640 | The genes induced by signal transducer and activators of transcription (STAT)3 and STAT5 in mammary epithelial cells define the roles of these STATs in mammary development. | Mol Endocrinol | 2006 | https://conductscience.org/library/papers/16293640 | PubMed |
| 8 | 20952588 | PTP1B suppresses prolactin activation of Stat5 in breast cancer cells. | Am J Pathol | 2010 | https://conductscience.org/library/papers/20952588 | PubMed |
| 9 | 15340066 | Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation. | Mol Cell Biol | 2004 | https://conductscience.org/library/papers/15340066 | PubMed |
| 10 | 31548545 | Breast cancer. | Nat Rev Dis Primers | 2019 | https://conductscience.org/library/papers/31548545 | PubMed |
| 11 | 32525891 | Loss of STAT6 leads to anchorage-independent growth and trastuzumab resistance in HER2+ breast cancer cells. | PLoS One | 2020 | https://conductscience.org/library/papers/32525891 | PubMed |
| 12 | 32111215 | Role of STAT3 signaling pathway in breast cancer. | Cell Commun Signal | 2020 | https://conductscience.org/library/papers/32111215 | PubMed |
| 13 | 3144043 | A DNA binding protein regulated by IL-4 and by differentiation in B cells. | Science | 1988 | https://conductscience.org/library/papers/3144043 | PubMed |
| 14 | 29744876 | Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition. | Int J Cancer | 2018 | https://conductscience.org/library/papers/29744876 | PubMed |
| 15 | 28441382 | Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers. | Br J Cancer | 2017 | https://conductscience.org/library/papers/28441382 | PubMed |
| 16 | 26979778 | A novel bisindole-PBD conjugate inhibits angiogenesis by regulating STAT3 and VEGF in breast cancer cells. | Life Sci | 2016 | https://conductscience.org/library/papers/26979778 | PubMed |
| 17 | 29679903 | Isoharringtonine inhibits breast cancer stem-like properties and STAT3 signaling. | Biomed Pharmacother | 2018 | https://conductscience.org/library/papers/29679903 | PubMed |
| 18 | 32156637 | Regulation of cancer cell signaling pathways as key events for therapeutic relevance of edible and medicinal mushrooms. | Semin Cancer Biol | 2022 | https://conductscience.org/library/papers/32156637 | PubMed |
| 19 | 2236065 | ISGF3, the transcriptional activator induced by interferon alpha, consists of multiple interacting polypeptide chains. | Proc Natl Acad Sci U S A | 1990 | https://conductscience.org/library/papers/2236065 | PubMed |
| 20 | 12563297 | Interleukin-12 and the regulation of innate resistance and adaptive immunity. | Nat Rev Immunol | 2003 | https://conductscience.org/library/papers/12563297 | PubMed |
Cited by65
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 96 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42941825 | JAK-STAT Signaling: Mechanisms and Therapeutics in Stem Cell Biology. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42941825 | PubMed |
| 42669662 | PI3K/AKT signaling pathway: molecular crossroads in tumorigenesis and therapeutic innovation. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42669662 | PubMed |
| 42444932 | GNL3L-LMNB1 signaling axis promotes lung squamous cell carcinoma growth and ferroptosis resistance via NF-κB activation. | J Thorac Dis | 2026 | https://conductscience.org/library/papers/42444932 | PubMed |
| 42360103 | Inflammation and carcinogenesis: molecular targets and small-molecule intervention strategies. | J Enzyme Inhib Med Chem | 2026 | https://conductscience.org/library/papers/42360103 | PubMed |
| 42242229 | STAT3 interference-driven nanomodulators reverse lipid metabolism-associated chemoresistance and potentiate metalloimmunotherapy in breast cancer. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42242229 | PubMed |
| 42232184 | Natural products in treating sepsis-associated lung and liver injuries by mediating ferroptosis, current progress, and future perspective. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42232184 | PubMed |
| 41992363 | Cancer in transition: discovery of tumor-intrinsic transcriptional programs shaping the immune and microenvironmental landscape. | Biomark Res | 2026 | https://conductscience.org/library/papers/41992363 | PubMed |
| 41977380 | Breast Cancer-Derived Extracellular Vesicle miR-425-5p (miR-425) Promotes Brain Metastasis via Activating Astrocytes Through the Novel miR-425-ZNF24-CCL8 Signaling Axis. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41977380 | PubMed |
| 41906639 | Role of Janus kinase-signal transducer and activator of transcription signaling pathway in hormonal cancer therapeutic resistance and lineage plasticity. | Endocrinology | 2026 | https://conductscience.org/library/papers/41906639 | PubMed |
| 41789586 | IL‑6: A key player in the EGFR‑TKI‑resistant tumor microenvironment and its therapeutic implications (Review). | Int J Oncol | 2026 | https://conductscience.org/library/papers/41789586 | PubMed |
| 41716028 | STAT1 accelerates cutaneous melanoma progression through TUBB4A expression regulation. | Mol Med Rep | 2026 | https://conductscience.org/library/papers/41716028 | PubMed |
| 41667440 | Ulcerative colitis: signaling pathways, therapeutic targets and interventional strategies. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/41667440 | PubMed |
| 41466772 | Dexmedetomidine Suppresses Mitochondrial Autophagy and Apoptosis While Promoting Proliferation in Breast Cancer Cells in vitro via PI3K/AKT Signaling. | Breast Cancer (Dove Med Press) | 2025 | https://conductscience.org/library/papers/41466772 | PubMed |
| 41465298 | Sulfatide Acts as a Regulatory Molecule Controlling β1 Integrin-STAT5 Signaling and BOLA2-Dependent Apoptotic Pathway in Breast Cancer Cells. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41465298 | PubMed |
| 41398194 | Apatinib-Induced STAT1/NK axis activation augments PD-1 inhibitor efficacy in advanced Hepatocellular Carcinoma. | Sci Rep | 2025 | https://conductscience.org/library/papers/41398194 | PubMed |
| 41376217 | Four-dimensional data independent acquisition proteomics and metabolomics reveal mechanisms of hydrogen-rich water at Zusanli (ST36) point against triple-negative breast cancer in mice. | J Tradit Chin Med | 2025 | https://conductscience.org/library/papers/41376217 | PubMed |
| 41205803 | Flavonoid-modulated JAK-STAT signaling mitigates malignant transformation and drug resistance in breast tumors: A clinically relevant 3PM-guided innovation. | J Adv Res | 2026 | https://conductscience.org/library/papers/41205803 | PubMed |
| 41111895 | p-Cymene Targets Multiple Oncogenic Pathways in Hepatocellular Carcinoma: Insights From Network Pharmacology and In Vitro Studies. | Food Sci Nutr | 2025 | https://conductscience.org/library/papers/41111895 | PubMed |
| 41075009 | Enhancing anti-tumor immunity by targeting BATF and the STAT1/PD-L1 pathway in cervical carcinoma. | Cell Mol Life Sci | 2025 | https://conductscience.org/library/papers/41075009 | PubMed |
| 40949156 | Emerging opportunities to treat drug-resistant breast cancer: Discovery of novel small-molecule inhibitors against different targets. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40949156 | PubMed |
Genes118
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35995341
GET https://conductscience.org/api/papers/v1/35995341/references?page=2